In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Journal of Urology

• Publication date

  1981-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)54360-8PMID 6166758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.

  1980cited by this paper
• Cell surface antigens of human renal cancer defined by autologous typing

  1979cited by this paper
• Prevention of death from metastases by immune RNA therapy.

  1978cited by this paper
• Fractionation of immune RNA capable of transferring tumor-specific cellular cytotoxicity.

  1978cited by this paper
• Immune RNA Therapy for Renal Cell Carcinoma: Survival and Immunologic Monitoring

  1977cited by this paper
• Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.

  1977cited by this paper
• Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients

  1976cited by this paper
• In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.

  1976cited by this paper
• Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays.

  1975cited by this paper
• A long‐term 51chromium assay for in vitro cell‐mediated tumor immunity. Correlation with simultaneously performed microplate assays

  1975cited by this paper
• Immune cytolysis of rat tumor cells mediated by syngeneic "immune" RNA.

  1974cited by this paper
• Studies on specificity of cell-mediated immunity to human tumors.

  1974cited by this paper
• Specificity of cellular immunity to renal cell carcinoma.

  1974cited by this paper
• Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.

  1973cited by this paper
• Reactivity of lymphocytes from normal persons on cultured tumor cells.

  1973cited by this paper
• Monkey to human transfer of delayed hypersensitivity in vitro with RNA extracts.

  1972cited by this paper
• Expression of Allelic Immunoglobulin in Homozygous Rabbits Injected with RNA Extract

  1971cited by this paper
• Demonstration of cell‐mediated immunity to human neoplasms of various histological types

  1971cited by this paper
• Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells.

  1971cited by this paper
• Cellular immunity to renal carcinomas in man

  1971cited by this paper
• RNA-mediated transfer of lymphocyte vs target cell activity.

  1969cited by this paper
• RNA-Mediated Transfer of Lymphocyte vs Target Cell Activity∗

  1968cited by this paper
• TRANSFER OF HEIGHTENED IMMUNITY TO SKIN HOMOGRAFTS BY LYMPHOID RNA.

  1964cited by this paper
• ANTIBODY FORMATION INITIATED IN VITRO

  1963cited by this paper
• Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen.

  1963cited by this paper
• Ribonucleic Acid in "Transformation" of Lymphoid Cells

  1962cited by this paper

• Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: implications for immunomodulation in HIV infection.

  2005cites this paper
• Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaB.

  2003cites this paper
• Regulatory RNA induces the production of IFN-γ, but not IL-4 in human lymphocytes: Role of RNA-dependent protein inase (PKR) and NF-κB

  2003cites this paper
• Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA

  2002cites this paper
• Effect of the calcium phosphate-mediated RNA uptake on the transfer of cellular immunity of a synthetic peptide of HIV-1 to human lymphocytes by exogenous RNA

  2001cites this paper
• Application of the Interferon Minipellet to Human Renal Cell Carcinoma in Nude Mice

  1997cites this paper
• Immunotherapy of renal cell carcinoma

  1993cites this paper
• Immunotherapy of advanced renal cancer.

  1990cites this paper
• Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma.

  1989cites this paper
• In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinoma.

  1989cites this paper
• [Interferon therapy in urology].

  1989cites this paper
• Carcinoma of the Kidney

  1989cites this paper
• Update in cancer chemotherapy: genitourinary tract cancer, Part 1.

  1987cites this paper
• Approaches to the treatment of renal cell carcinoma

  1987cites this paper
• Immunologic Aspects of Malignant Renal Disease

  1987cites this paper
• Nephrectomy in metastatic renal cell carcinoma.

  1987cites this paper
• Failure of immunotherapy for metastatic renal cell carcinoma.

  1986cites this paper
• Failurel of Immunotherapy for Metastatic Renal Cell Carcinoma

  1986cites this paper
• Treatment of renal cell carcinoma with renal infarction, delayed nephrectomy, medroxyprogesterone, and xenogeneic immune RNA.

  1985cites this paper
• Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid.

  1984cites this paper
• [Effect of exogenous RNA preparations on the antitumor activity of the splenocytes in C3HA mice].

  1984cites this paper
• Human lymphoblastoid interferon therapy for advanced renal cell carcinoma.

  1984cites this paper
• Immunotherapy of renal cell carcinoma

  1984cites this paper
• Renal cell carcinoma--angioinfarction.

  1984cites this paper
• New human renal carcinoma cell line established from a patient with erythrocytosis.

  1983cites this paper
• Treatment of metastatic renal cell carcinoma.

  1983cites this paper
• Treatment of advanced renal cell carcinoma--traditional methods and innovative approaches.

  1983cites this paper
• Urologic Cancer: Chemotherapeutic Principles and Management

  1983cites this paper
• Management of Isolated Metastases and Advanced Renal Carcinoma

  1983cites this paper
• Immunologic therapies of kidney carcinoma.

  1983cites this paper
• Current therapy for renal cell carcinoma.

  1982cites this paper